None listed
Conditions
Brief summary
Depression, cardiovascular disease (CVD) risk factors and cognitive impairment are key causes of disability and poor health outcomes. Comorbidity of these leads to an even worse prognosis. The primary aim of this randomised controlled trial is to determine the effect of an evidence-based internet intervention program for depression on depressive mood symptoms in patients being treated for, or at risk of developing, CVD. Participants will be drawn from the longitudinal cohort study of healthy volunteers, the 45 and Up Study. Participants will be selected on the basis of self-reported history of CVD or multiple risk-factors for developing CVD and positive screen for depressive symptoms, as measured by the Kessler-10. The 12 week intervention will compare the effectiveness of online cognitive behavioural therapy (e-couch) with an attention control placebo (HealthWatch website). Follow-up will occur post-intervention and again at 6 and 12 months. Therefore, secondary aims of this trial are to determine the immediate and 12 month efficacy of the internet intervention on cognitive function and adherence to cardiovascular treatment and exercise.
Interventions
The intervention of interest for this study is e-couch for depression, a 12-week, online, multimedia application that provides mental health literacy (e.g. what causes mood problems, how to prevent them and how to treat them) and a set of online evidence-based cognitive behavioural therapy interventions designed to equip the user with strategies to improve their mood and emotional state, along with a workbook to track progress and record experiences. Participants will be asked to visit e-couch to complete a module once a week (spending approximately 30 minutes to an hour) for twelve weeks.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Participant in the logitudinal cohort, the 45 and Up Study 2. Aged 45 to 75 years at date of sampling 3. Self-reported history of cardiovascular disease as collected within the 45 and Up Study baseline data 4. Positive screen for depressive symptoms as collected within the baseline 45 and Up Study data 5. Provided informed consent to participate and link their data with that of Medicare Australia and NSW Health Services.
Exclusion criteria
Exclusion criteria will be applied at the time of screening entry to the trial as follows: 1. No depressive symptoms, as determined using the PHQ-9 (scores less than or equal to 7 on the 27-point scale). 2. Suicidal ideation determined from the PHQ-9. 3. Current psychotherapy of any form.